<< Back To Article
People With HIV Have High Rates of Cardiac Dysfunction

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*



Why is there no mention of the new antibody PRO-140 (now Leronlimab), as it will likely be approved by the FDA? Leronlemab can improve lives of most long-term HIV-positive individuals by eliminating significant side effects, reduce dosing to once/week, and eliminate harm (e.g., heart problems, etc.) that result from long-term use of HAART. The cocktail has served us well, but now it's time for a new class of treatment that is more effective and less than many others for most patients?

March 15, 2019 New York


Hot topics